Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
about
P1343
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.
P2860
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
@en
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization.
@nl
type
label
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
@en
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization.
@nl
prefLabel
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
@en
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization.
@nl
P2093
P2860
P356
P1433
P1476
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
@en
P2093
Aline L Nocon
Irene O Justiniano
Julie T Soon
Quach Truong
Sandra Wissmueller
P2860
P304
P356
10.7150/JCA.14645
P577
2016-05-21T00:00:00Z